Carisma Therapeutics Inc. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets
Carisma Therapeutics Inc. had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets of $80.31 million as of 2023-03-07, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Asset Acquired, Asset
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets · last filed 2025-03-31
- 2023-03-07: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $80.31M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets |
|---|---|
| 2023-03-07 | $80.31M 10-K · filed 2025-03-31 |